Nuclear Medicine Therapeutics Market Report

Japan Nuclear Medicine Therapeutics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 14, 2019
  • PAGES：135
  • REPORT CODE：GMM225217
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Nuclear Medicine Therapeutics market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Nuclear Medicine Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Nuclear Medicine Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Nordion

    • JSC Isotope

    • Siemens Healthcare (PETNET Solutions)

    • IBA Group

    • Triad Isotopes


    By Type:

    • Alpha Emitters

    • Beta Emitters

    • Brachytherapy


    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Medicine Therapeutics Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Nuclear Medicine Therapeutics Market Size and Growth Rate of Alpha Emitters from 2014 to 2026

      • 1.3.2 Japan Nuclear Medicine Therapeutics Market Size and Growth Rate of Beta Emitters from 2014 to 2026

      • 1.3.3 Japan Nuclear Medicine Therapeutics Market Size and Growth Rate of Brachytherapy from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Nuclear Medicine Therapeutics Market Size and Growth Rate of Application 1 from 2014 to 2026

      • 1.4.2 Japan Nuclear Medicine Therapeutics Market Size and Growth Rate of Application 2 from 2014 to 2026

      • 1.4.3 Japan Nuclear Medicine Therapeutics Market Size and Growth Rate of Application 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Nuclear Medicine Therapeutics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Nuclear Medicine Therapeutics by Major Types

      • 3.4.1 Market Size and Growth Rate of Alpha Emitters

      • 3.4.2 Market Size and Growth Rate of Beta Emitters

      • 3.4.3 Market Size and Growth Rate of Brachytherapy

    4 Segmentation of Nuclear Medicine Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Nuclear Medicine Therapeutics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Nuclear Medicine Therapeutics in Application 1

      • 4.4.2 Market Size and Growth Rate of Nuclear Medicine Therapeutics in Application 2

      • 4.4.3 Market Size and Growth Rate of Nuclear Medicine Therapeutics in Application 3


    5 Market Analysis by Regions

    • 5.1 Japan Nuclear Medicine Therapeutics Production Analysis by Regions

    • 5.2 Japan Nuclear Medicine Therapeutics Consumption Analysis by Regions


    6 Hokkaido Nuclear Medicine Therapeutics Landscape Analysis

    • 6.1 Hokkaido Nuclear Medicine Therapeutics Landscape Analysis by Major Types

    • 6.2 Hokkaido Nuclear Medicine Therapeutics Landscape Analysis by Major End-Users


    7 Tohoku Nuclear Medicine Therapeutics Landscape Analysis

    • 7.1 Tohoku Nuclear Medicine Therapeutics Landscape Analysis by Major Types

    • 7.2 Tohoku Nuclear Medicine Therapeutics Landscape Analysis by Major End-Users


    8 Kanto Nuclear Medicine Therapeutics Landscape Analysis

    • 8.1 Kanto Nuclear Medicine Therapeutics Landscape Analysis by Major Types

    • 8.2 Kanto Nuclear Medicine Therapeutics Landscape Analysis by Major End-Users


    9 Chubu Nuclear Medicine Therapeutics Landscape Analysis

    • 9.1 Chubu Nuclear Medicine Therapeutics Landscape Analysis by Major Types

    • 9.2 Chubu Nuclear Medicine Therapeutics Landscape Analysis by Major End-Users


    10 Kinki Nuclear Medicine Therapeutics Landscape Analysis

    • 10.1 Kinki Nuclear Medicine Therapeutics Landscape Analysis by Major Types

    • 10.2 Kinki Nuclear Medicine Therapeutics Landscape Analysis by Major End-Users


    11 Chugoku Nuclear Medicine Therapeutics Landscape Analysis

    • 11.1 Chugoku Nuclear Medicine Therapeutics Landscape Analysis by Major Types

    • 11.2 Chugoku Nuclear Medicine Therapeutics Landscape Analysis by Major End-Users


    12 Shikoku Nuclear Medicine Therapeutics Landscape Analysis

    • 12.1 Shikoku Nuclear Medicine Therapeutics Landscape Analysis by Major Types

    • 12.2 Shikoku Nuclear Medicine Therapeutics Landscape Analysis by Major End-Users


    13 Kyushu Nuclear Medicine Therapeutics Landscape Analysis

    • 13.1 Kyushu Nuclear Medicine Therapeutics Landscape Analysis by Major Types

    • 13.2 Kyushu Nuclear Medicine Therapeutics Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Nordion

      • 14.1.1 Nordion Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 JSC Isotope

      • 14.2.1 JSC Isotope Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Siemens Healthcare (PETNET Solutions)

      • 14.3.1 Siemens Healthcare (PETNET Solutions) Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 IBA Group

      • 14.4.1 IBA Group Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Triad Isotopes

      • 14.5.1 Triad Isotopes Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 103 Figures and 181 Tables)

     

    • Figure Japan Nuclear Medicine Therapeutics Market Size and Growth Rate of Alpha Emitters from 2014 to 2026

    • Figure Japan Nuclear Medicine Therapeutics Market Size and Growth Rate of Beta Emitters from 2014 to 2026

    • Figure Japan Nuclear Medicine Therapeutics Market Size and Growth Rate of Brachytherapy from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Nuclear Medicine Therapeutics Market Size and Growth Rate of Application 1 from 2014 to 2026

    • Figure Japan Nuclear Medicine Therapeutics Market Size and Growth Rate of Application 2 from 2014 to 2026

    • Figure Japan Nuclear Medicine Therapeutics Market Size and Growth Rate of Application 3 from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Nuclear Medicine Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Nuclear Medicine Therapeutics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Nuclear Medicine Therapeutics by Different Types from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine Therapeutics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Alpha Emitters

    • Figure Market Size and Growth Rate of Beta Emitters

    • Figure Market Size and Growth Rate of Brachytherapy

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Nuclear Medicine Therapeutics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine Therapeutics by Different End-Users from 2014 to 2026

    • Figure Japan Nuclear Medicine Therapeutics Market Size and Growth Rate of Application 1 from 2014 to 2026

    • Figure Japan Nuclear Medicine Therapeutics Market Size and Growth Rate of Application 2 from 2014 to 2026

    • Figure Japan Nuclear Medicine Therapeutics Market Size and Growth Rate of Application 3 from 2014 to 2026

    • Table Japan Nuclear Medicine Therapeutics Production by Regions

    • Table Japan Nuclear Medicine Therapeutics Production Share by Regions

    • Figure Japan Nuclear Medicine Therapeutics Production Share by Regions in 2014

    • Figure Japan Nuclear Medicine Therapeutics Production Share by Regions in 2018

    • Figure Japan Nuclear Medicine Therapeutics Production Share by Regions in 2026

    • Table Japan Nuclear Medicine Therapeutics Consumption by Regions

    • Table Japan Nuclear Medicine Therapeutics Consumption Share by Regions

    • Figure Japan Nuclear Medicine Therapeutics Consumption Share by Regions in 2014

    • Figure Japan Nuclear Medicine Therapeutics Consumption Share by Regions in 2018

    • Figure Japan Nuclear Medicine Therapeutics Consumption Share by Regions in 2026

    • Table Hokkaido Nuclear Medicine Therapeutics Consumption by Types from 2014 to 2026

    • Table Hokkaido Nuclear Medicine Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Nuclear Medicine Therapeutics Consumption Share by Types in 2014

    • Figure Hokkaido Nuclear Medicine Therapeutics Consumption Share by Types in 2018

    • Figure Hokkaido Nuclear Medicine Therapeutics Consumption Share by Types in 2026

    • Table Hokkaido Nuclear Medicine Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Nuclear Medicine Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Nuclear Medicine Therapeutics Consumption Share by End-Users in 2014

    • Figure Hokkaido Nuclear Medicine Therapeutics Consumption Share by End-Users in 2018

    • Figure Hokkaido Nuclear Medicine Therapeutics Consumption Share by End-Users in 2026

    • Table Tohoku Nuclear Medicine Therapeutics Consumption by Types from 2014 to 2026

    • Table Tohoku Nuclear Medicine Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Nuclear Medicine Therapeutics Consumption Share by Types in 2014

    • Figure Tohoku Nuclear Medicine Therapeutics Consumption Share by Types in 2018

    • Figure Tohoku Nuclear Medicine Therapeutics Consumption Share by Types in 2026

    • Table Tohoku Nuclear Medicine Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Tohoku Nuclear Medicine Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Nuclear Medicine Therapeutics Consumption Share by End-Users in 2014

    • Figure Tohoku Nuclear Medicine Therapeutics Consumption Share by End-Users in 2018

    • Figure Tohoku Nuclear Medicine Therapeutics Consumption Share by End-Users in 2026

    • Table Kanto Nuclear Medicine Therapeutics Consumption by Types from 2014 to 2026

    • Table Kanto Nuclear Medicine Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Kanto Nuclear Medicine Therapeutics Consumption Share by Types in 2014

    • Figure Kanto Nuclear Medicine Therapeutics Consumption Share by Types in 2018

    • Figure Kanto Nuclear Medicine Therapeutics Consumption Share by Types in 2026

    • Table Kanto Nuclear Medicine Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Kanto Nuclear Medicine Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Nuclear Medicine Therapeutics Consumption Share by End-Users in 2014

    • Figure Kanto Nuclear Medicine Therapeutics Consumption Share by End-Users in 2018

    • Figure Kanto Nuclear Medicine Therapeutics Consumption Share by End-Users in 2026

    • Table Chubu Nuclear Medicine Therapeutics Consumption by Types from 2014 to 2026

    • Table Chubu Nuclear Medicine Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Chubu Nuclear Medicine Therapeutics Consumption Share by Types in 2014

    • Figure Chubu Nuclear Medicine Therapeutics Consumption Share by Types in 2018

    • Figure Chubu Nuclear Medicine Therapeutics Consumption Share by Types in 2026

    • Table Chubu Nuclear Medicine Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Chubu Nuclear Medicine Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Nuclear Medicine Therapeutics Consumption Share by End-Users in 2014

    • Figure Chubu Nuclear Medicine Therapeutics Consumption Share by End-Users in 2018

    • Figure Chubu Nuclear Medicine Therapeutics Consumption Share by End-Users in 2026

    • Table Kinki Nuclear Medicine Therapeutics Consumption by Types from 2014 to 2026

    • Table Kinki Nuclear Medicine Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Kinki Nuclear Medicine Therapeutics Consumption Share by Types in 2014

    • Figure Kinki Nuclear Medicine Therapeutics Consumption Share by Types in 2018

    • Figure Kinki Nuclear Medicine Therapeutics Consumption Share by Types in 2026

    • Table Kinki Nuclear Medicine Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Kinki Nuclear Medicine Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Nuclear Medicine Therapeutics Consumption Share by End-Users in 2014

    • Figure Kinki Nuclear Medicine Therapeutics Consumption Share by End-Users in 2018

    • Figure Kinki Nuclear Medicine Therapeutics Consumption Share by End-Users in 2026

    • Table Chugoku Nuclear Medicine Therapeutics Consumption by Types from 2014 to 2026

    • Table Chugoku Nuclear Medicine Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Nuclear Medicine Therapeutics Consumption Share by Types in 2014

    • Figure Chugoku Nuclear Medicine Therapeutics Consumption Share by Types in 2018

    • Figure Chugoku Nuclear Medicine Therapeutics Consumption Share by Types in 2026

    • Table Chugoku Nuclear Medicine Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Chugoku Nuclear Medicine Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Nuclear Medicine Therapeutics Consumption Share by End-Users in 2014

    • Figure Chugoku Nuclear Medicine Therapeutics Consumption Share by End-Users in 2018

    • Figure Chugoku Nuclear Medicine Therapeutics Consumption Share by End-Users in 2026

    • Table Shikoku Nuclear Medicine Therapeutics Consumption by Types from 2014 to 2026

    • Table Shikoku Nuclear Medicine Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Nuclear Medicine Therapeutics Consumption Share by Types in 2014

    • Figure Shikoku Nuclear Medicine Therapeutics Consumption Share by Types in 2018

    • Figure Shikoku Nuclear Medicine Therapeutics Consumption Share by Types in 2026

    • Table Shikoku Nuclear Medicine Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Shikoku Nuclear Medicine Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Nuclear Medicine Therapeutics Consumption Share by End-Users in 2014

    • Figure Shikoku Nuclear Medicine Therapeutics Consumption Share by End-Users in 2018

    • Figure Shikoku Nuclear Medicine Therapeutics Consumption Share by End-Users in 2026

    • Table Kyushu Nuclear Medicine Therapeutics Consumption by Types from 2014 to 2026

    • Table Kyushu Nuclear Medicine Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Nuclear Medicine Therapeutics Consumption Share by Types in 2014

    • Figure Kyushu Nuclear Medicine Therapeutics Consumption Share by Types in 2018

    • Figure Kyushu Nuclear Medicine Therapeutics Consumption Share by Types in 2026

    • Table Kyushu Nuclear Medicine Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Kyushu Nuclear Medicine Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Nuclear Medicine Therapeutics Consumption Share by End-Users in 2014

    • Figure Kyushu Nuclear Medicine Therapeutics Consumption Share by End-Users in 2018

    • Figure Kyushu Nuclear Medicine Therapeutics Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Nordion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion

    • Figure Sales and Growth Rate Analysis of Nordion

    • Figure Revenue and Market Share Analysis of Nordion

    • Table Product and Service Introduction of Nordion

    • Table Company Profile and Development Status of JSC Isotope

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of JSC Isotope

    • Figure Sales and Growth Rate Analysis of JSC Isotope

    • Figure Revenue and Market Share Analysis of JSC Isotope

    • Table Product and Service Introduction of JSC Isotope

    • Table Company Profile and Development Status of Siemens Healthcare (PETNET Solutions)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siemens Healthcare (PETNET Solutions)

    • Figure Sales and Growth Rate Analysis of Siemens Healthcare (PETNET Solutions)

    • Figure Revenue and Market Share Analysis of Siemens Healthcare (PETNET Solutions)

    • Table Product and Service Introduction of Siemens Healthcare (PETNET Solutions)

    • Table Company Profile and Development Status of IBA Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IBA Group

    • Figure Sales and Growth Rate Analysis of IBA Group

    • Figure Revenue and Market Share Analysis of IBA Group

    • Table Product and Service Introduction of IBA Group

    • Table Company Profile and Development Status of Triad Isotopes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triad Isotopes

    • Figure Sales and Growth Rate Analysis of Triad Isotopes

    • Figure Revenue and Market Share Analysis of Triad Isotopes

    • Table Product and Service Introduction of Triad Isotopes

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US